Search
for
Sort by
Research 571–600 of 1000+
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Pathobiology of chemotherapy-induced hair loss
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Baiting Proteins with C<sub>60</sub>
- MENSTRUAL DISORDERS IN ADOLESCENTS
- PCOS in adolescents
- Dermatology of androgen-related disorders
- ACNE
- Hair and scalp disorders in ethnic populations
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- Sulfatase inhibitors: a patent review
- Endocrine-skin interactions
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Recent advances in oxasteroids chemistry
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Update on the dermatologic use of systemic glucocorticosteroids
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- Understanding and Addressing Hair Disorders in Transgender Individuals
- Congenital adrenal hyperplasia
- Novel inhibitors of 5α-reductase
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer